Growth factors increase retroviral transduction but decrease clonogenic potential of umbilical cord blood CD34+ cells

Area of Science:

• Hematology
• Molecular Biology
• Gene Therapy

Background:

• Gene marking and therapy efficiency relies on stable CD34+ cell transduction.
• Umbilical cord blood is a valuable source of CD34+ cells.
• Growth factor incubation may influence retroviral vector transduction of CD34+ cells.

Purpose of the Study:

• To evaluate the impact of growth factor incubation on CD34+ cell transduction efficiency.
• To determine optimal incubation and infection schedules for retroviral vector delivery.
• To assess the effect of transduction protocols on the clonogenic potential of CD34+ cells.

Main Methods:

• Purified CD34+ cells were infected with a retroviral vector (LXSN).
• Cells were incubated with Interleukin-3 (IL-3), Interleukin-6 (IL-6), and stem cell factor (SCF) under various schedules.
• Transduction efficiency was assessed using clonogenic assays and PCR analyses after 7-day expansion with EPO, IL-3, and GM-CSF.

Main Results:

• Transduction efficiency increased with longer incubation periods with growth factors.
• The duration of stimulation and infection influenced the types of cells transduced.
• A 12-hour stimulation followed by a 3-hour infection significantly enhanced clonogenic potential after 7 days, while a 48-hour infection led to a complete loss of potential.

Conclusions:

• Short incubation/infection schedules achieve high transduction efficiency in purified CD34+ cells.
• Optimization of incubation and infection timing is critical for maintaining cell function post-transduction.
• Gene therapy protocols can be improved by fine-tuning CD34+ cell transduction parameters.